日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Phase I/II clinical trial of a melanoma vaccine targeting shared non-mutated antigens and a shared mutated BRAF neoantigen with an agonistic CD40 antibody (CDX-1140) plus TLR3 agonist (poly-ICLC)

针对共同的非突变抗原和共同的突变BRAF新抗原的黑色素瘤疫苗的I/II期临床试验,采用激动性CD40抗体(CDX-1140)和TLR3激动剂(poly-ICLC)

Ninmer, Emily K; Petroni, Gina R; Gastman, Brian R; Gaughan, Elizabeth M; Isaacs, James M; Haden, Kathleen; Kaur, Varinder; Wages, Nolan A; Chianese-Bullock, Kimberly A; Smith, Kelly T; Wright, Paul; Bryant, Jennifer; Dunlap-Brown, Marya; Engel, Jack A; Bekiranov, Stefan; Mauldin, Ileana S; Truong, Thach-Giao; Bullock, Timothy N J; Slingluff, Craig L Jr

Antibiotics and Surgical Site Infection in Expander-Based Breast Reconstruction Trial (ASSERT)

基于扩张器的乳房重建术中抗生素与手术部位感染的比较研究(ASSERT)

Kaur, Surinder; Gastman, Brian; Broderick, Kristen P; Momoh, Adeyiza O; Phillips, Brett T; Schwarz, Graham; Hanson, Summer E; Hespe, Geoffrey E; Cooney, Carisa M; Sommers, Katie; Leu, Cheng-Shiun; Rohde, Christine H

Long-Term Efficacy and Safety of Lifileucel Tumor-Infiltrating Lymphocyte Cell Therapy in Patients With Advanced Melanoma: A 5-Year Analysis of the C-144-01 Study

Lifileucel肿瘤浸润淋巴细胞疗法治疗晚期黑色素瘤患者的长期疗效和安全性:C-144-01研究的5年分析

Medina, Theresa; Chesney, Jason A; Kluger, Harriet M; Hamid, Omid; Whitman, Eric D; Cusnir, Mike; Thomas, Sajeve S; Wermke, Martin; Domingo-Musibay, Evidio; Phan, Giao Q; Kirkwood, John M; Larkin, James; Weber, Jeffrey; Graf Finckenstein, Friedrich; Chou, Jeffrey; Gastman, Brian; Wu, Xiao; Fiaz, Rana; Sarnaik, Amod A

Lifileucel tumor-infiltrating lymphocyte cell therapy in patients with unresectable or metastatic mucosal melanoma after disease progression on immune checkpoint inhibitors

Lifileucel肿瘤浸润淋巴细胞疗法用于治疗免疫检查点抑制剂治疗后病情进展的不可切除或转移性黏膜黑色素瘤患者

Kluger, Harriet; Grigoleit, Götz Ulrich; Thomas, Sajeve; Domingo-Musibay, Evidio; Chesney, Jason A; Sanmamed, Miguel F; Medina, Theresa; Ziemer, Mirjana; Whitman, Eric; Finckenstein, Friedrich Graf; Gastman, Brian; Chou, Jeffrey; Wu, Xiao; Sulur, Giri; Fiaz, Rana; Qi, Rongsu; Sarnaik, Amod A

The science of tumor-infiltrating lymphocytes (TIL): perspectives from the SITC Surgery Committee

肿瘤浸润淋巴细胞 (TIL) 的科学:来自 SITC 外科委员会的观点

Coukos, George; Donia, Marco; Gastman, Brian R; Goff, Stephanie L; Gros, Alena; Harari, Alexandre; Hernandez, Sophia; Ito, Fumito; Maker, Ajay V; Mullinax, John E; Murthy, Pranav; Pai, Sara I; Prabhakaran, Sangeetha; Restifo, Nicholas P; Silver, Natalie L; Marincola Smith, Paula; Turcotte, Simon; Wagner, Patrick L; Yang, James C; Lotze, Michael T

Art of TIL immunotherapy: SITC's perspective on demystifying a complex treatment

TIL免疫疗法的艺术:SITC对揭开复杂疗法神秘面纱的见解

Turcotte, Simon; Donia, Marco; Gastman, Brian; Besser, Michal; Brown, Robert; Coukos, George; Creelan, Benjamin; Mullinax, John; Sondak, Vernon K; Yang, James C; Rohaan, Maartje W; Marie Svane, Inge; Lotze, Michael T; Haanen, John B A G; Goff, Stephanie L

Efficacy and safety of one-time autologous tumor-infiltrating lymphocyte cell therapy in patients with recurrent and/or metastatic head and neck squamous cell carcinoma

一次性自体肿瘤浸润淋巴细胞疗法治疗复发性和/或转移性头颈部鳞状细胞癌患者的疗效和安全性

Ferris, Robert L MD,; Leidner, Rom S; Chung, Christine H; Jimeno, Antonio; Lee, Sylvia M; Sukari, Ammar; Nieva, Jorge J; Grilley-Olson, Juneko E; Redman, Rebecca; Wong, Stuart J; Villaflor, Victoria M; Misleh, Jamal; Finckenstein, Friedrich Graf; Chou, Jeffrey; Gastman, Brian; Fiaz, Rana; Catlett, Melissa; Yi, Min; Cohen, Ezra E W

A Phase I, First-in-Human, Dose-Escalation, Expansion Trial of Cytokine-Encoding Synthetic mRNA Mixture Alone or with Cemiplimab in Advanced Solid Tumors

一项针对晚期实体瘤的细胞因子编码合成mRNA混合物单药或联合Cemiplimab治疗的I期、首次人体、剂量递增、扩展试验

Bechter, Oliver; Loquai, Carmen; Champiat, Stephane; Baurain, Jean-Francois; Grob, Jean-Jacques; Utikal, Jochen; Rottey, Sylvie; Berrocal, Alfonso; Hassel, Jessica C; Arance, Ana; Sanmamed, Miguel F; Boers-Sonderen, Marye; Gastman, Brian; Gebhardt, Christoffer; Delafontaine, Brant; Sahin, Ugur; Türeci, Özlem; Brueck, Patrick; Abbadessa, Giovanni; Marpadga, Rahul; Lee, Helen; Yang, Yue; Buday, Barbara; Di Genova, Gianfranco; Wang, Hong; Xia, Binfeng; Lee, Joon Sang; Lebbe, Céleste

NT-I7, a novel long-acting interleukin-7, promotes anti-PD-1 efficacy in an autologous humanized melanoma model

NT-I7 是一种新型长效白细胞介素-7,可在自体人源化黑色素瘤模型中增强抗 PD-1 疗法的疗效。

Phoon, Yee Peng; Wolfarth, Alexandra A; Funchain, Pauline; Ko, Jennifer S; Choi, Donghoon; Dedkova, Eliska; Bateman, Daniela Duarte; Corvin, Jessica; Melenhorst, Jan J; Gastman, Brian R

LRIG1 engages ligand VISTA and impairs tumor-specific CD8+ T cell responses

LRIG1 与配体 VISTA 结合,并削弱肿瘤特异性 CD8+ T 细胞反应。

Hieu Minh Ta ,Dia Roy ,Keman Zhang ,Tyler Alban ,Ivan Juric ,Juan Dong ,Prerana B Parthasarathy ,Sachin Patnaik ,Elizabeth Delaney ,Cassandra Gilmour ,Amin Zakeri ,Nidhi Shukla ,Amit Rupani ,Yee Peng Phoon ,Caini Liu ,Stefanie Avril ,Brian Gastman ,Timothy Chan ,Li Lily Wang